Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial
Infect Dis Ther
.
2024 May;13(5):1159-1160.
doi: 10.1007/s40121-024-00947-w.
Authors
Julie M Strizki
1
,
Jay A Grobler
2
,
Nicholas Murgolo
2
,
Arthur Fridman
2
,
Matthew G Johnson
2
,
Jiejun Du
2
,
Patricia Carmelitano
2
,
Michelle L Brown
2
,
Amanda Paschke
2
,
Carisa De Anda
2
Affiliations
1
Merck & Co., Inc., 90 E Scott Ave, Rahway, NJ, 07065, USA.
[email protected]
.
2
Merck & Co., Inc., 90 E Scott Ave, Rahway, NJ, 07065, USA.
PMID:
38662333
PMCID:
PMC11098983
DOI:
10.1007/s40121-024-00947-w
No abstract available
Publication types
Published Erratum